Non-prescription products market in Poland 2025

• Sales value of non-prescription products in brick-and-mortar stores and pharmacies, as well as through online channels, including online pharmacies and e-commerce stores
• Sales value of selected non-prescription product categories across individual distribution channels, including brick-and-mortar stores and pharmacies, as well as online retailers
• Market and distribution channel forecasts for 2024-2029, covering brick-and-mortar stores and pharmacies, online stores and online pharmacies, together with an analysis of the key factors expected to influence the market during the forecast period
• Market conditions and long-term trends
• The report analyses consumer behaviour, including purchase frequency and locations, buyer profiles, recent changes in shopping habits, purchase plans, factors influencing the choice of sales channel, and the occasions on which OTC medicines and dietary supplements are purchased. It also presents trends and sales data for key categories, including urinary tract products, cardiovascular products, immunity and cold remedies, digestive health products, nervous system products, muscle, bone and joint

• Market value and dynamics: The report presents the value of the non-prescription products market in Poland, its real growth rate and development forecasts for the next five years.
• Sales channels and product categories: It analyses sales value across individual distribution channels, their growth prospects and the key OTC product categories.
• Trends and market drivers: The report assesses the impact of major events, inflation and the epidemiological situation on market development through 2030.
• Data and consumer research: It combines verified sales data with the results of PMR’s proprietary consumer research and expert commentary from analysts.

The report supports key business decisions and is particularly useful for board members, senior executives, and professionals responsible for marketing, sales and business development, including:

• Manufacturers of OTC medicines, dietary supplements and other parapharmaceutical products
• Companies specialising in pharmacy sales of non-prescription products and dietary supplements
• Businesses involved in online and non-pharmacy distribution
• Advertising agencies serving the pharmaceutical sector
• Private equity funds, financial institutions
• Research and academic institutions
• Embassies, government and industry agencies, banks